FibroGen

$40.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (+0.37%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell FibroGen and other stocks, options, and ETFs commission-free!

About FGEN

FibroGen, Inc Common Stock, also called FibroGen, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA. The listed name for FGEN is FibroGen, Inc Common Stock.

CEO
Enrique A. Conterno
Employees
531
Headquarters
San Francisco, California
Founded
1993
Market Cap
3.66B
Price-Earnings Ratio
Dividend Yield
Average Volume
574.89K
High Today
$41.17
Low Today
$39.97
Open Price
$40.45
Volume
379.37K
52 Week High
$51.56
52 Week Low
$22.65

Collections

FGEN Earnings

-$1.12
-$0.33
$0.47
$1.26
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, After Hours

You May Also Like